Evidence map›Paper›PMID 34981111›Full record

ArticleBriefings in bioinformatics2022

TIGER: technical variation elimination for metabolomics data using ensemble learning architecture.

Siyu Han, Jialing Huang, Francesco Foppiano, Cornelia Prehn, Jerzy Adamski, Karsten Suhre, Ying Li, Giuseppe Matullo, Freimut Schliess, Christian Gieger and 2 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. An epidemiological introduction to human metabolomic investigations.Trends in endocrinology and metabolism: TEM · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siyu HanSchool of Medicine, Technical University of Munich, Germany.
Jialing HuangLudwig Maximilian University of Munich, Germany.
Francesco FoppianoLudwig Maximilian University of Munich, Germany.
Cornelia PrehnHead of Metabolomics Lab at Metabolomics and Proteomics Core Facility, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH).
Jerzy AdamskiNational University of Singapore, University of Ljubljana, Slovenia and Technical University of Munich, Germany.
Karsten SuhreWeill Cornell Medicine and director of the Bioinformatics Core, Qatar.
Ying LiCollege of Computer Science and Technology, Key Laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, Jilin University, Changchun, China.
Giuseppe MatulloHuman Genetics and group leader of the Genomics Variation, Complex Diseases and Population Medicine Unit at the Turin University, Italy.
Freimut SchliessDirector Science & Innovation at Profil Institut für Stoffwechselforschung (GmbH).
Christian GiegerResearch Unit of Molecular Epidemiology at the Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH).
Annette PetersLudwig Maximilian University of Munich, Germany.
Rui Wang-SattlerHelmholtz Zentrum München, German Research Center for Environmental Health (GmbH).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large metabolomics datasets inevitably contain unwanted technical variations which can obscure meaningful biological signals and affect how this information is applied to personalized healthcare. Many methods have been developed to handle unwanted variations. However, the underlying assumptions of many existing methods only hold for a few specific scenarios. Some tools remove technical variations with models trained on quality control (QC) samples which may not generalize well on subject samples. Additionally, almost none of the existing methods supports datasets with multiple types of QC samples, which greatly limits their performance and flexibility. To address these issues, a non-parametric method TIGER (Technical variation elImination with ensemble learninG architEctuRe) is developed in this study and released as an R package (https://CRAN.R-project.org/package=TIGERr). TIGER integrates the random forest algorithm into an adaptable ensemble learning architecture. Evaluation results show that TIGER outperforms four popular methods with respect to robustness and reliability on three human cohort datasets constructed with targeted or untargeted metabolomics data. Additionally, a case study aiming to identify age-associated metabolites is performed to illustrate how TIGER can be used for cross-kit adjustment in a longitudinal analysis with experimental data of three time-points generated by different analytical kits. A dynamic website is developed to help evaluate the performance of TIGER and examine the patterns revealed in our longitudinal analysis (https://han-siyu.github.io/TIGER_web/). Overall, TIGER is expected to be a powerful tool for metabolomics data analysis.

Indexed as

AlgorithmsMetabolomicsHumansMachine LearningReproducibility of ResultsResearch Designensemble learninglongitudinal analysismachine learningmetabolomicspredictive modelling

Identifiers

PMID34981111
PMCPMC8921617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.